A recent study investigated the association of recipient and donor JAK2 haplotypeGGCC_46/1 and the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in a series of 124 AML patients [60]. This evidence concerns the gene JAK2 and acute myeloid leukemia.